School of Life Sciences, Jilin University, Changchun, China.
School of Music, Herzen University, Moika River Embankment, St. Petersburg, Russia.
Complement Ther Med. 2024 Nov;86:103090. doi: 10.1016/j.ctim.2024.103090. Epub 2024 Sep 28.
Patients undergoing hemodialysis (HD) face significant challenges; however, non-pharmaceutical interventions hold potential for enhancing their quality of life. This paper evaluates the effects of music therapy on various mental and physiological outcomes in patients undergoing HD.
This systematic review and meta-analysis followed the PRISMA 2020 guidelines. A comprehensive database search conducted up to May 21, 2024, identified studies for inclusion based on PICOS criteria. The methodological quality of these studies was assessed using the Cochrane risk-of-bias tool and Review Manager 5.4. For the meta-analysis, R and Stata/SE 15.1 were used, applying a random-effects model in cases of significant heterogeneity, and a fixed-effects model when heterogeneity was minimal.
Twenty-four studies involving 1703 participants were analyzed. Music therapy significantly decreased anxiety (SMD: -0.72, 95 % CI: -0.97 to -0.46, I²: 83 %), pain (SMD: -1.22, 95 % CI: -1.68 to -0.75, I²: 93 %), depression (SMD: -0.85, 95 % CI: -1.31 to -0.39, I²: 77 %), stress (SMD: -0.93, 95 % CI: -1.17 to -0.68, I²: 41 %), and adverse reactions associated with HD (SMD: -0.67, 95 % CI: -0.88 to -0.46, I²: 0 %), all showing strong effect sizes (p < 0.001 for all). However, no significant changes were observed in sleep quality, fatigue, satisfaction with HD, systolic or diastolic blood pressure, heart rate, or finger temperature. A slight reduction in respiration rate (p = 0.0072) and an increase in oxygen saturation (p = 0.0056) were noted. While music therapy showed promising results, the notable heterogeneity in pain and anxiety outcomes suggests careful interpretation, although no significant publication bias was detected.
Music therapy has demonstrated encouraging outcomes in improving the well-being of patients undergoing HD, particularly in reducing anxiety, pain, and stress. However, due to notable heterogeneity and methodological issues such as small sample sizes and inconsistent blinding, further high-quality research is needed to confirm these findings and establish more robust evidence.
接受血液透析(HD)的患者面临着重大挑战;然而,非药物干预有可能提高他们的生活质量。本文评估了音乐疗法对 HD 患者各种心理和生理结果的影响。
本系统评价和荟萃分析遵循 PRISMA 2020 指南。全面的数据库搜索截至 2024 年 5 月 21 日进行,根据 PICOS 标准确定纳入研究。使用 Cochrane 偏倚风险工具和 Review Manager 5.4 评估这些研究的方法学质量。对于荟萃分析,在存在显著异质性的情况下使用随机效应模型,在异质性最小的情况下使用固定效应模型。
分析了 24 项涉及 1703 名参与者的研究。音乐疗法显著降低了焦虑(SMD:-0.72,95%CI:-0.97 至-0.46,I²:83%)、疼痛(SMD:-1.22,95%CI:-1.68 至-0.75,I²:93%)、抑郁(SMD:-0.85,95%CI:-1.31 至-0.39,I²:77%)、应激(SMD:-0.93,95%CI:-1.17 至-0.68,I²:41%)和与 HD 相关的不良反应(SMD:-0.67,95%CI:-0.88 至-0.46,I²:0%),所有结果均显示出较强的效应大小(p<0.001 均)。然而,睡眠质量、疲劳、对 HD 的满意度、收缩压或舒张压、心率或指温没有显著变化。呼吸频率略有下降(p=0.0072),氧饱和度增加(p=0.0056)。尽管音乐疗法显示出有希望的结果,但疼痛和焦虑结果的显著异质性表明需要谨慎解释,尽管没有检测到显著的发表偏倚。
音乐疗法在改善 HD 患者的健康状况方面显示出令人鼓舞的结果,特别是在降低焦虑、疼痛和压力方面。然而,由于显著的异质性和方法学问题,如样本量小和不一致的盲法,需要进一步的高质量研究来证实这些发现并建立更可靠的证据。